T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy

BACKGROUND: FOLFOX-based adjuvant chemotherapy is a benefit for high-risk stage II and stage III colon cancer after curative resection. But, the prognostic factor or predictive marker for the efficacy of FOLFOX remains unclear. This study was aimed to identify the prognostic value and cumulative imp...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:World J Surg Oncol
Huvudupphovsmän: An, Min Sung, Yoo, Jong Han, Kim, Kwang Hee, Bae, Ki Beom, Choi, Chang Soo, Hwang, Jin Won, Kim, Ji Hyun, Kim, Bo Mi, Kang, Mi Seon, Oh, Min Kyung, Hong, Kwan Hee
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336700/
https://ncbi.nlm.nih.gov/pubmed/25889520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-015-0488-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk